Journal article · 2026 · Open access

Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials

Rose Gelineau‐Morel, James Steven Leeder, Jonathan B. Wagner

Clinical Pharmacology & Therapeutics · Published 26 October 2026 · DOI 10.1002/cpt.70532

Open PDFView at the publisherCite this paper

In brief

“Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials” is a 2026 journal article by Rose Gelineau‐Morel and 2 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 17 November 2026. It is open access: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
0
References
9
Authors
3

Abstract

Model-informed drug development (MIDD) and model-informed precision dosing (MIPD) increasingly guide drug development, regulatory decision-making, and individualized therapy but rely on robust data. Current models inadequately represent children with medical complexity (CMC), whose unique physiology, comorbidities, and polypharmacy contribute to substantial variability in drug exposure and response. We propose a framework using genotype-stratified trials to characterize pharmacogenetic sources of variability, informing MIDD and MPID models while helping identify additional determinants of therapeutic response in CMC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gelineau‐Morel, R., Leeder, J. S., & Wagner, J. B. (2026). Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70532

MLA 9

Gelineau‐Morel, Rose, et al. “Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70532.

Chicago

Gelineau‐Morel, Rose, James Steven Leeder, and Jonathan B. Wagner. 2026. “Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70532.

Harvard

Gelineau‐Morel, R., Leeder, J. S. and Wagner, J. B. (2026) ‘Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70532.

IEEE

R. Gelineau‐Morel, J. S. Leeder, and J. B. Wagner, “Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70532.

BibTeX

@article{gelineaumorel2026advancing,
  title     = {{Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials}},
  author    = {Gelineau‐Morel, Rose and Leeder, James Steven and Wagner, Jonathan B.},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2026},
  doi       = {10.1002/cpt.70532},
  url       = {https://doi.org/10.1002/cpt.70532}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices

  • children with medical complexity
  • model-informed precision dosing
  • model-informed drug development
  • pharmacogenetics
  • polypharmacy
  • comorbidities
  • drug exposure variability
  • treatment response

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Gelineau‐Morel, R., Leeder, J. S., & Wagner, J. B. (2026). Advancing Therapeutics for Children with Medical Complexity: The Role of Model‐Informed Precision Dosing and Genotype‐Stratified Trials. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70532

How many times has this paper been cited?

0 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

Rose Gelineau‐Morel, James Steven Leeder, Jonathan B. Wagner.

What is the DOI of this paper?

10.1002/cpt.70532, permanently at https://doi.org/10.1002/cpt.70532. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.